SG47556A1 - N-[3-[2-(1H-imidazol-1-yl) ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts - Google Patents
N-[3-[2-(1H-imidazol-1-yl) ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable saltsInfo
- Publication number
- SG47556A1 SG47556A1 SG1996002818A SG1996002818A SG47556A1 SG 47556 A1 SG47556 A1 SG 47556A1 SG 1996002818 A SG1996002818 A SG 1996002818A SG 1996002818 A SG1996002818 A SG 1996002818A SG 47556 A1 SG47556 A1 SG 47556A1
- Authority
- SG
- Singapore
- Prior art keywords
- pyrimidinamine
- imidazol
- thienyl
- ethoxy
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/816,335 US5162328A (en) | 1991-12-31 | 1991-12-31 | N-[3-[2-(1H-imidazol-1-yl)ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts |
Publications (1)
Publication Number | Publication Date |
---|---|
SG47556A1 true SG47556A1 (en) | 1998-04-17 |
Family
ID=25220310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG1996002818A SG47556A1 (en) | 1991-12-31 | 1992-11-23 | N-[3-[2-(1H-imidazol-1-yl) ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts |
Country Status (16)
Country | Link |
---|---|
US (1) | US5162328A (ko) |
EP (1) | EP0549880B1 (ko) |
JP (1) | JPH05271227A (ko) |
KR (1) | KR930012761A (ko) |
AT (1) | ATE171178T1 (ko) |
AU (1) | AU651539B2 (ko) |
CA (1) | CA2086357A1 (ko) |
DE (1) | DE69227015T2 (ko) |
DK (1) | DK0549880T3 (ko) |
ES (1) | ES2121809T3 (ko) |
FI (1) | FI925951A (ko) |
HU (1) | HUT66943A (ko) |
NO (1) | NO301476B1 (ko) |
NZ (1) | NZ245513A (ko) |
SG (1) | SG47556A1 (ko) |
ZA (1) | ZA9210120B (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2628474A1 (en) * | 2005-11-03 | 2007-05-10 | Sgx Pharmaceuticals, Inc. | Pyrimidinyl-thiophene kinase modulators |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4788195A (en) * | 1986-01-13 | 1988-11-29 | American Cyanamid Company | 4,5,6-substituted-N-(substituted-phenyl)-2-pyrimidinamines |
ATE135699T1 (de) * | 1986-01-13 | 1996-04-15 | American Cyanamid Co | 4,5,6-substituierte 2-pyrimidinamine |
-
1991
- 1991-12-31 US US07/816,335 patent/US5162328A/en not_active Expired - Fee Related
-
1992
- 1992-11-23 DE DE69227015T patent/DE69227015T2/de not_active Expired - Fee Related
- 1992-11-23 EP EP92119890A patent/EP0549880B1/en not_active Expired - Lifetime
- 1992-11-23 ES ES92119890T patent/ES2121809T3/es not_active Expired - Lifetime
- 1992-11-23 AT AT92119890T patent/ATE171178T1/de not_active IP Right Cessation
- 1992-11-23 DK DK92119890T patent/DK0549880T3/da active
- 1992-11-23 SG SG1996002818A patent/SG47556A1/en unknown
- 1992-12-09 NO NO924760A patent/NO301476B1/no unknown
- 1992-12-18 NZ NZ24551392A patent/NZ245513A/en unknown
- 1992-12-24 JP JP4357370A patent/JPH05271227A/ja active Pending
- 1992-12-29 CA CA002086357A patent/CA2086357A1/en not_active Abandoned
- 1992-12-30 ZA ZA9210120A patent/ZA9210120B/xx unknown
- 1992-12-30 FI FI925951A patent/FI925951A/fi unknown
- 1992-12-30 KR KR1019920027617A patent/KR930012761A/ko not_active Application Discontinuation
- 1992-12-30 AU AU30462/92A patent/AU651539B2/en not_active Ceased
- 1992-12-30 HU HU9204172A patent/HUT66943A/hu unknown
Also Published As
Publication number | Publication date |
---|---|
ZA9210120B (en) | 1994-04-12 |
NO924760D0 (no) | 1992-12-09 |
ATE171178T1 (de) | 1998-10-15 |
FI925951A0 (fi) | 1992-12-30 |
EP0549880A1 (en) | 1993-07-07 |
AU651539B2 (en) | 1994-07-21 |
DK0549880T3 (da) | 1999-06-14 |
AU3046292A (en) | 1993-07-08 |
NO301476B1 (no) | 1997-11-03 |
NO924760L (no) | 1993-07-01 |
EP0549880B1 (en) | 1998-09-16 |
DE69227015T2 (de) | 1999-03-25 |
US5162328A (en) | 1992-11-10 |
HU9204172D0 (en) | 1993-04-28 |
HUT66943A (en) | 1995-01-30 |
NZ245513A (en) | 1994-07-26 |
CA2086357A1 (en) | 1993-07-01 |
KR930012761A (ko) | 1993-07-21 |
JPH05271227A (ja) | 1993-10-19 |
ES2121809T3 (es) | 1998-12-16 |
FI925951A (fi) | 1993-07-01 |
DE69227015D1 (de) | 1998-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO933093D0 (no) | Monohydrat av 5-(2-(4-(1,2-benzisotiazol-3-yl)-1-piperazinyl)-etyl)-6-klor-1,3-dihydro-2h-indol-2-on hydroklorid | |
HU9600834D0 (en) | Quinazoline derivatives | |
KR950016738A (ko) | 알쯔하이머 질병의 억제 방법 | |
DK0664126T3 (da) | Hæmning af trombin | |
DK0957099T3 (da) | Heterocykliske carboxamider | |
UY26480A1 (es) | Inhibidores de n - (5 - ( 5 - alquil - 2 - oxazolil) metil ) tio) - 2 - tiazolil) - carboxamida de cinasas dependientes de ciclina | |
NZ237565A (en) | Substituted thiazolidinones, oxazolidinones or imidazolidinones and antiinflammatory pharmaceutical compositions thereof | |
UA26930C2 (uk) | Засіб для іhгібуваhhя еhдометріозу | |
UY26481A1 (es) | Inhibidores de n - (5 - ( ( (5 - alquil - 2 - oxazolil) metil) tio) - 2 - tiazolil) - carboxamida de cinasas dependientes de ciclina. | |
HK21595A (en) | Use of 1-(3-dimethyl-amino)propyl)-1-phenylphthalenes for the treatment of cerebrovascular disorders | |
NO944925L (no) | Fremgangsmåte for å öke libido i post-menopausale kvinner | |
DE69428665D1 (de) | Hemmung von CNS-Problemen bei Frauen nach der Menopause | |
HUP9802995A2 (hu) | Szubsztituált szulfonil-amino-(tio)karbonil-származékok, intermedierjeik, a vegyületeket hatóanyagként tartalmazó herbicid készítmények, valamint eljárás a vegyületek, és készítmények előállítására és alkalmazására | |
NO903640L (no) | Fremgangsmaate for fremstilling av 2-(rs)-substituerte 2,3-dihydro-5-oksy-4,6,7-trimetylbenzofuraner. | |
PT790236E (pt) | Pro-farmacos de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil-6-cloro-1,3-di-hidro-2h-indol-2-ona | |
SG47556A1 (en) | N-[3-[2-(1H-imidazol-1-yl) ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts | |
IL125002A0 (en) | Novel substituted 4-(1H-benzimidazol-2-yl) [1,4] diazepanes useful for the treatment of allergic diseases | |
MX9205186A (es) | Derivados de 4-[4-[4-(4-hidroxifenil)-1-piperazinil]-fenil]-5-metil-3h-1,2,4-triazo l-3-ona | |
SE9704770D0 (sv) | New use | |
ATE203406T1 (de) | Hemmung von hirsutismus und alopecia bei frauen | |
NZ336585A (en) | 2,6-dimethyl-4-(3-nitro-phenyl)-5-methoxycarbonyl-1,4-dihydropyridine-3-carboxylate derivatives substituted by N-[5-(1H-2-pyrrolyl)-5-oxopentyl] or [4-(2-thienoyl or 2,4,6-trimethoxybenzoyl)-butyl]-pyrrolid-3-ine or piperid-3-ine |